Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (31-40 of 638) with videos related to

Pageof 64
Sort By:
Cardiovascular Research|December 26, 2015
Perilipin2/adipophilin and ApoA-1 team up to combat atherosclerosisBenoit Pourcet, Bart Staels
Expert Opinion on Investigational Drugs|August 29, 2014
GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetesBertrand Cariou, Bart Staels
Circulation Research|August 6, 2011
Circadian control of epigenetic modifications modulates metabolismHélène Duez, Bart Staels
Current Opinion in Lipidology|March 14, 2007
The orphan nuclear receptor Rev-erbalpha: a transcriptional link between circadian rhythmicity and cardiometabolic diseaseCoralie Fontaine, Bart Staels
Trends in Pharmacological Sciences|April 7, 2007
FXR: a promising target for the metabolic syndrome?Bertrand Cariou, Bart Staels
Journal of Hepatology|April 19, 2006
The expanding role of the bile acid receptor FXR in the small intestineBertrand Cariou, Bart Staels
Nuclear Receptor Signaling|April 11, 2006
Potential roles of ROR-alpha in cardiovascular endocrinologySaara Laitinen, Bart Staels
Trends in Cardiovascular Medicine|April 26, 2008
Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanismsRéjane Paumelle, Bart Staels
Current Opinion in Lipidology|October 16, 2009
Combination therapy of statins and fibrates in the management of cardiovascular riskCatherine Fiévet, Bart Staels
Journal of Hepatology|January 15, 2014
Failing FXR expression in the liver links aging to hepatic steatosisPhilippe Lefebvre, Bart Staels
Pageof 64

Showing results (31-40 of 638) with videos related to

Sort By:
Pageof 64
Cardiovascular Research|December 26, 2015
Perilipin2/adipophilin and ApoA-1 team up to combat atherosclerosisBenoit Pourcet, Bart Staels
Expert Opinion on Investigational Drugs|August 29, 2014
GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetesBertrand Cariou, Bart Staels
Circulation Research|August 6, 2011
Circadian control of epigenetic modifications modulates metabolismHélène Duez, Bart Staels
Current Opinion in Lipidology|March 14, 2007
The orphan nuclear receptor Rev-erbalpha: a transcriptional link between circadian rhythmicity and cardiometabolic diseaseCoralie Fontaine, Bart Staels
Trends in Pharmacological Sciences|April 7, 2007
FXR: a promising target for the metabolic syndrome?Bertrand Cariou, Bart Staels
Journal of Hepatology|April 19, 2006
The expanding role of the bile acid receptor FXR in the small intestineBertrand Cariou, Bart Staels
Nuclear Receptor Signaling|April 11, 2006
Potential roles of ROR-alpha in cardiovascular endocrinologySaara Laitinen, Bart Staels
Trends in Cardiovascular Medicine|April 26, 2008
Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanismsRéjane Paumelle, Bart Staels
Current Opinion in Lipidology|October 16, 2009
Combination therapy of statins and fibrates in the management of cardiovascular riskCatherine Fiévet, Bart Staels
Journal of Hepatology|January 15, 2014
Failing FXR expression in the liver links aging to hepatic steatosisPhilippe Lefebvre, Bart Staels
Pageof 64